Swiss pharmaceutical giant Novartis has announced a $1 billion (SFr1.02 billion) research and development investment in China over the next five years.
The investment will include a significant expansion of the Novartis Institute of BioMedical Research in Shanghai.
Demand for healthcare in China is growing rapidly, Novartis said in a statement. "In addition, the burden of disease now includes more chronic diseases associated with lifestyle choices," it added. More...
Don't miss:
- Swiss pharma giants pay millions to US politicians...
- Novartis boss earned nearly 40 million dollars in 2008...
- Animal rights militants bomb Novartis chairman's home...
- How Big Pharma dopes and dupes...
- India's waterways massively polluted by Big Pharma...
No comments:
Post a Comment